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Introduction and outline of our model building strategy
In the current work we developed an individual-based simulation model of HIV transmission for men who have sex with men (MSM) that contains a separable temporal exponential random graph model 1 (STERGM) for sexual partnership formation. STERGMs are the dynamic, stochastic extension of crosssectional exponential random graph models (ERGMs) and as such allow for simulation of stochastically evolving sexual partnership networks. 2, 3 These models accommodate statistical dependence among partnerships, based on factors that are characteristic of the population as a whole, such as: the total number of men in any partnership, the average number of partners per man, and, our case, differences in these parameters by HIV serostatus of current and potential new partners for each man.
Figure S1 provides a schematic of how each part of the model was developed and implemented, with links to corresponding sections with additional details included in this appendix. The first step is to fit an exponential random graph model, describing how MSM form sexual partnerships. Data for the parameters of this model come from an online survey of US MSM, the demographics of this sample population have been described previously. 4 Once the model for partnership formation is fit, a model for how partnerships end is also constructed. Dissolution of partnerships is approximated using the method derived by Carnegie et al, 5 and dynamic extensions to the R statnet packages. [6] [7] [8] Once the partnership network statistics for both partnership formation and dissolution are estimated the next step is to simulate both partnership formation and dissolution as well as HIV transmission, disease progression, and interventions such as HIV testing and treatment within the simulated population. We increment time in 5-day increments and at each time step we update summary measures such as the current viral load for each man, his total contribution to the viral load (summed over all prior time points) and his current diagnosis status. We then repeat the process of partnership's forming and ending, disease transmission, HIV diagnosis and treatment at the next time point. We use customized extensions to the R package EpiModel 9 to control all of the testing intervention parameters within our dynamic stochastic model of HIV transmission. Because the time horizon of interest in changes in HIV incidence is limited to 3 years, we do not model either entrance to or exit from the study population.
We choose to simulate a population of 5250 MSM, mainly because when this project began this arbitrary size was the largest that we could run on a standard computer without running out of memory.
Figure S1: Development and flow of our individual based model of sexual transmission of HIV for MSM.
Step 1: Fit ERGM model for partnership formation to data from an online survey 4 Parameters included in this phase of the modeling:
Total number of Men in the simulation, by true and perceived Serostatus in Table S1 Total number of partnerships in the network Selective mixing by perceived HIV status, with the number of ties between individuals of the same perceived serostatus being greater than expected by chance and different for each serostatus (See Table S2 )
Number of individuals of each serostatus with no partner
Number of individuals of each serostatus with ≥ 2 partners
Step 2: Use the ERGM model and dissolution parameters to simulate
Partnership formation
Partnership dissolution based on durations of partnership by serostatus (Table S3 Weibull Mean, also derived from data from reference 4 )
Step 3: Simulate Disease Transmission, HIV diagnosis, Treatment initiation and Viral load
Transmission From HIV-infected to uninfected partners Per act probability of transmission varied by stage of infection and viral load, going to zero if the infected man was treated. For the untreated population the average per act probability of transmission was 0.00056 Men in perceived concordant positive and concordant negative relationships had a probability an additional act per 5 days that was 3 times higher than those in discordant or unknown status relationships Diagnosis occurs through testing with a proportion of the population eligible to test at each time point based on both a percentage that never test (random assignment as a non-tester occurs at the beginning of the simulation) and the testing interval intervention being evaluated. For the baseline scenario testing frequency is assigned to each man at the start of the simulation, including a randomly generated date of last test basted on reported testing frequencies in our observed population.
Treatment and viral suppression were fixed at a percentage of the newly diagnosed population initiating treatment at each simulated time point to maintain a fixed average percentage on treatment over time. Treatment leads to immediate viral suppression and eliminated transmission from the treated HIV infected persons in the same time point. 
Step 4: Update outcome measures and retain information for analysis
Baseline prevalence and serostatus awareness
The population includes 5250 men who have sex with men, and we simulate both network formation and dissolution and HIV transmission dynamics over a three year period. Baseline perceived HIV serostatus is based on the information collected in our survey sample, 4 while prevalence of diagnosed and undiagnosed infection are set to be consistent with data from most sites participating in CDC surveillance of MSM [10] [11] [12] and population based surveys of this risk group [13] [14] [15] . The model is incremented in 5 day time steps for efficiency, based on two assumptions that should make this simplification valid:
1) The average partnership duration is an order of magnitude larger than this time increment 2) MSM have sex on average once in this time period 16 We model HIV transmission as occurring through anal intercourse acts without a condom within an ongoing partnership, with an allowance for additional one-time acts with other HIV-infected individuals occurring outside this partnership as a probability of a one-time act per five days as described below.
We consider only an average rate of transmission per sex act in which no condom was used, and do not attempt to account for differences in risk associated with insertive, receptive or both types of anal intercourse occurring within a given sexual encounter. Similar to a model considered by Goodreau 2 ,  we model the risk of transmission as a daily per act probability of transmission that changes over the infected lifetime of each individual based on changes in their HIV viral load. For those aware that they are infected with HIV, we also include a parameter for the overall probability of accessing HIV antiretroviral therapy and achieving full suppression of detectable HIV virus.
Entry into and exit from the population
Although migration into and out of a given community of MSM undoubtedly occurs, the majority of entries into a given population of MSM are through aging into sexual debut and exiting due to death either from HIV or other causes. Others 2,3,17 have used rates of birth and death based on US population dynamics, but these effects should be minimal in our 3 year time scale. However, by not allowing for births and deaths our population will not settle into equilibrium values for HIV prevalence, as no one with infection will die and be removed from the simulation. Thus we actually capture the short term dynamics in a closed system, rather than long-range dynamics of a system in equilibrium. It should be pointed out that both incidence and prevalence are increasing rapidly in some subsets of the MSM population in the US, and insights from a short term evaluation of the impact of an intervention on a system that is not at equilibrium [18] [19] may help to guide expectations for short term outcomes of interventions better than estimating effects on longer timescales 17 . In future work we will expand the model to include entry to and exit from the system to see how our interventions might affect HIV incidence once the system achieves equilibrium.
Parameterization of the separable temporal random graph model for partnership formation and other aspects of model for transmission dynamics.
This work is one of only a few papers 2, 3, 17 in the literature in which partnership formation probabilities differ based on the perceived HIV serostatus of the two men interested in forming a partnership. This assumption is based on data collected in an online survey 4 which we have used to parameterize the following STERGM model.
STERGM Model parameters
In defining the model, yi,j,t is a variable describing whether MSM i and j are in a sexual partnership at time t taking the value 1 when they are and 0 otherwise. The variable Y e i,j,t describes the rest of the network, i.e. all other sexual partnerships among the 5250 total men in our simulation, EXCLUDING the partnership information for MSM i and j.
Partnership formation is described by: This form of the model is written such that the log odds of a partnership forming between MSM i and MSM j at time t, given both that i and j were not in a partnership together at the last time step and the composition of the rest of the network under study, is a function of 10 parameters. The terms included in our model are: a) the total number of partnerships in the network (edges), b) the selective mixing by perceived HIV status, so that the number of ties between individuals of the same perceived HIV status (perceived serostatus concordance) is greater than would be expected by chance, and different for each perceived status, c) the number of individuals of each serostatus who do not currently have a partner (degree 0) or d) who have 2 or more partners (concurrent partnerships).
These network statistics are calculated for each of three groups of perceived serostatus: unknown serostatus for those never tested; negative serostatus for those whose most recent test result was reported as negative; and positive for those who have received a positive HIV test result. For those with either an unknown or negative perceived status, a proportion of them are actually infected with HIV, they just don't know it. Note that, as in traditional multivariable generalized linear models (GLMs), the edges term (which describes the total number of partnerships not defined by any other parameter, and is equivalent to an intercept term in a GLM) captures the log odds of forming a partnership for those with discordant perceived HIV status.
Parameters for the model are averaged over data reported for both main and causal partnerships in the survey that provides the source of these data. 4 Table S2 provides network characteristics that were used to parameterize the initial model. There are subtle differences in both the number of partners (expressed as mean degree in Table S2 ) by serostatus awareness, but the most interesting finding in terms of transmission is that HIV-positive participants reported more partners overall and more perceived discordant partnerships than HIV-negative participants. However, in our survey HIV-infected participants were also more likely to form partnerships with other HIV-infected participants (31% of all partnerships were between 2 HIV-infected men, compared with 5% that would have been expected to be observed by chance); as a result many of the sex partners of HIV-infected men are not at risk of acquiring HIV infection, because they are already infected. characteristics, but without considering the overall structure of the sexual network in their model [20] [21] [22] .
Still others have used deterministic models with groups of high and lower risk MSM, but these capture neither the overlap we have found to be common in the sexual partnerships of MSM (both men with perceived HIV-negative and perceived HIV-positive status have >1 partnership ongoing at the same time on average, Table S2 ), nor the stochastic nature of HIV transmission [23] [24] [25] . In this analysis, we take a different approach than others because we have found that many non-main partnerships are recurring, if not ongoing, relationships, so we do not treat them as one-time events. Instead we capture the duration of all partnerships and use these data to describe the duration of partnerships using differing rates of partnership dissolution by perceived serostatus. Thus, our partnership durations tend to be shorter on average than those reported in other similar work that employs STERGM models. 2, 17 In 2,3,17 average partnership duration was 1248 days, or between 2 and 6 times longer than the durations used in our model. Again, partnerships were longer for those in concordant relationships, except that there is a group in longstanding known discordant relationships with only a main partner, with this group having the second longest mean relationship duration, behind only those in concordant HIV-positive main only relationships. Overall the means were an order of magnitude larger for main only partners compared to those who also had casual or both types of partners in the preceding 6 months. However, even among men who report only casual partnerships in the preceding 6 months the mean duration of these partnerships was 5 months at a minimum for those in discordant partnerships or those where neither partner knew their HIV status. As a sensitivity analysis to attempt to quantify the importance of partnership duration to our main findings about the effects of testing interventions on HIV incidence, we reran the simulations with partnership durations set to one quarter of the lengths reported in Table   S3 .
Discussion of the importance of partnership duration as a model assumption
When we decreased the average duration of all partnerships modeled within our STERGM to 1/4 of median length of the duration observed in our data, incidence increased to a median of 3.84 (IQR: Thus, we found that partnership duration can impact overall HIV incidence, suggesting that structural interventions aimed at reducing the number of partners and encouraging stable partnerships could be important areas for future research [26] [27] [28] . The drastic differences in mean partnership duration that we found, with short partnership durations for serodiscordant men and the population that did not know their serostatus, lead to more frequent opportunities for the infected men in these groups to expose new partners to the virus. As has been reported by others 2, 17, 19 the mean degree of HIV-infected men who were aware of their infection is higher than that of HIV-negative men, this is in part the reason they are now infected. However, in our data, infected men who are aware of their infection were observed to be more likely to be in a relationship with other infected men, and for those relationships to be more stable than other combinations of HIV serostatus. Among those who know they are infected, the average durations for relationships with men who are of negative or unknown status was 332 days compared to 646 days for relationships with other HIV-infected men. The lack of effect of increasing testing frequency to more than annually is at least partially due to the average relationship lasting longer than one year.
Probability of having a one-time partner
Because we attempt to capture the duration of casual partnerships through shorter average partnership duration, the only portion of our sample of partnership distributions that remains poorly explained is the number of partnerships that are one-time events. In our data these account for 40% of all reported anal sex partners in the last 6 months. The proportion of all partnerships reported as onetime was substantially lower when participants reported knowing both their HIV status and that of their partner (35%) than when reporting unknown serostatus for themselves and or their partners (45%), suggesting the anonymous nature of a one-time sexual encounter precluded discussion of HIV serostatus. However, from the survey we were unable to ascertain the proportion of all one-time partnerships that were relevant for transmission, namely those in which one partner is HIV-infected, the other is not, and a condom is not used for the entire anal sex encounter. To keep the parameterization of these episodes simple, but still attempt to account for them in our model, we added an additional unprotected anal sex act in each simulated 5-day time step for serodiscordant partnerships with probability based on an exponential distribution. The probabilities were based those above; when one or both partners did not know their serostatus the 5-day probability of having an additional one-time act in addition to all ongoing relationships was 0.03, when both partners perceived themselves to be either HIV-negative or HIV-infected the 5-day probability of a one-time act was set to 0.014.
Evaluation of the underlying rate of HIV testing and its impact on our transmission models
The main goal of this analysis is to assess the impact of increasing average testing frequency from the baseline scenario, which results in approximately annual testing, to every 6 months and every 3 months. Changes in testing frequency result in more frequent updating of the perceived serostatus of the men in our simulated population, providing more accurate serostatus information leading to changes in partnership formation based on this perceived serostatus over time. We used data from our online survey of MSM 4 to define the baseline probability of HIV testing. Table S5 ) only resulted in an additional 90 day decrease in the time between infection and diagnosis.
Figure S2: Distribution of days from infection to diagnosis for a simulated population of 5250 MSM in the United States
Modeling the impact of men who never test on HIV incidence
Another difference between our STERGM model and others that have examined this question is that we have explicitly included a proportion of the MSM population that never tests for HIV, and can manipulate this proportion along with other aspects of testing interventions. Khanna et al 3, 17 attempted to account for the large proportion of MSM who never test for HIV through a scenario in which MSM test only once every 10 years on average, and found much higher incidence in this scenario compared to their baseline scenario where MSM test annually. In their model based on data from MSM in Australia 21 , Gray found that an intervention targeting the estimated 5% of MSM that have never tested and getting them to test annually would have a modest impact on HIV incidence. In our baseline model, 20% of the population has never been tested for HIV, higher than observed in venuebased samples of MSM 10-12 but consistent with or lower than population based estimates [13] [14] [15] . To consider the effects of a strategy which would get more MSM to test at least once (such as a social media campaign, routine testing in a hospital or other clinical setting, or other outreach to the MSM population that is not currently testing, we increased the proportion of the population that ever tests for HIV from the baseline value of 80% to 93% and 99%. We found (See Table in the main text) that, at baseline levels of testing frequency, test sensitivity, and treatment coverage, increasing the proportion of this group that received at least one HIV test had a small but linear relationship with HIV incidence. Figure S3 shows that, when combined with a test capable of detecting infection within 22 days and 100% viral suppression for those whose infection is diagnosed, synergistic effects similar to that shown for increasing the frequency of testing to once every 90 days can be achieved by reducing the proportion of MSM who never test from 20% to 7%. If social media or other campaigns could be targeted to this largely undescribed population, such a campaign would require a 20% increase in annual testing compared to baseline, and thus might be a more efficient strategy than one that would require a 400% increase in testing compared to the volume currently performed on MSM in the US.
Figure S3: Synergistic effects of accessing more of the population for testing while using a highly sensitive test and achieving 100% viral suppression among the population with diagnosed infection
*In this model HIV testing frequency was held constant at the baseline distribution observed in our online survey and thus does not contribute to infections averted. This can be compared to the effects reported in Figure S6 in which the proportion of MSM that never test was held constant while testing frequency, treatment coverage for the diagnosed population, and HIV test sensitivity were varied. * Future research is needed to better describe this group of MSM that never test for HIV despite recommendations to test at least annually, and to design interventions that would motivate them to join the population of MSM that do seek out testing for HIV.
Calculating the total circulating HIV viral load over time to document the impact (or lack thereof) of testing interventions
We also calculate and report the total circulating viral load, by diagnosis status of the men in the Figure S5 , we categorize perceived HIV status as diagnosed as HIVinfected, perceived to be HIV-negative even though they are infected and currently testing for HIV, or currently infected but with unknown serostatus for the group of men who do not seek HIV testing. For those who are diagnosed and access treatment we assume their viral load will be reduced to an undetectable level, and that at that point it does not contribute to the calculation of the total circulating viral load. We calculated the median of the total viral load in each category (diagnosed HIVinfection, undiagnosed but not testing, undiagnosed and currently testing for HIV) across 20 simulations for each of our model scenarios. Then, we compare the resulting proportions of circulating viral load over time in each category across model scenarios with different testing frequency distributions for the MSM who test.
In Figure S5 the rows represent the distribution of the: 1) Diagnosis status awareness of infected MSM, 2) the total circulating viral load and 3) the total number of HIV transmissions. The columns are different scenarios for HIV testing frequency. In the baseline scenario for column 1, on average MSM test approximately annually, but some test more or less frequently (9.3% test every 90 days, 14.3% test only once every 3 years). We modified this so that all men test closer to every 6 months, every 90 days, and every 5 days (weekly), with the results of these scenarios presented in columns 2-4 respectively.
In the first row, light blue is the proportion of all infections undiagnosed at the end of follow-up, light purple represents the proportion undiagnosed at the start of the simulation but diagnosed by the end (i.e. over 3 years of follow-up), dark purple is the proportion diagnosed at the start and red the proportion that never test. As testing frequency increases the proportion of all infections that remain undiagnosed decreases, but this is the smallest grouping of HIV-infected men at baseline.
In the second row the color coding is retained, with light blue corresponding to the proportion of the total viral load contributed by men while infected but undiagnosed (including during acute infection), purple is the proportion of the total circulating viral load contributed by those with diagnosed infection
Figure S5: Impact of testing frequency on transmission dynamics in a population where only 43% of those with diagnosed HIV infection achieve viral suppression
(under conditions where only 43.4% of the diagnosed population has their virus suppressed by therapy) and red corresponds to the viral load contributed by the MSM that never test. Columns 2-4 have orange sections corresponding to the percent of circulating virus removed compared to baseline, in this case through increases in testing frequency.
In the third row, information about the effect of test sensitivity on diagnosis category has been added.
In this row, dark blue represents the proportion of transmissions that arise from the population that is currently infected and testing but undiagnosed, including those testing false-negative based on the sensitivity of the test, and those testing infrequently such that they have been infected since their last test. The light blue is the transmissions in this group that occur within the first 22 days of infection and are currently deemed "unstoppable" through testing alone. Likewise the dark red shading represents transmissions arising from the population that never tests, and the pink corresponds to those transmissions occurring within the first 22 days for this subset. The purple again represents the proportion of transmissions from the diagnosed population.
The orange section now represents the proportion of transmissions removed compared to baseline, i.e. present in the baseline scenario but which did not occur in the counterfactual scenarios where testing frequency increased. For all three rows the data presented represent the changes in median values across testing scenarios, the interquartile ranges for these estimates overlapped for all scenarios at baseline values of treatment coverage.
Taken together Figure S5 shows that at baseline only 14% of the HIV-infected population is "up for grabs" from a testing frequency intervention's perspective. While this group does represent a disproportionate amount of the circulating viral load (row 2), testing alone only moves them to the diagnosed group and has a small impact on circulating viral load overall. The impact on onward transmission is therefore also small, with the confidence interval around the 10.65% of infections averted when comparing the scenario where MSM test every 90 days to baseline testing frequency including zero (-8.6%,26.8%). The non-significance is also shown in a lack of a trend for increasing testing frequency and percent of infections averted, with testing weekly having slightly fewer infections averted on average. Figure 2 in the main text shows that the median values of total circulating viral load decreased substantially when we parameterize the model such that the entire diagnosed population achieves viral suppression and in Figure3 in the main text this is also shown to lead to reductions in 3 year HIV incidence. Figure S6 is similar to Figure S3 , but for this figure we combine increasing testing frequency, increasing test sensitivity and increasing the proportion of the diagnosed population achieving viral suppression to 100% while holding the percentage that never test fixed at the baseline value of 20%. Figure S6 breaks down the reductions in observed median incidence into the effects of these three interventions as well additional reduction (7.69%) in incidence over and above what was observed when each intervention was applied to the population individually.
Figure S6: Contributions of 3 different interventions and the synergy between them to median reduction in incidence observed in 20 simulations of a population of 5250 MSM in the United States
Stochastic variation in models and implications for our main outcomes
Despite the computational intensity of building these models (each simulation takes on average 2 hours to run) we report 340 total simulations with large variability in incidence within a given model. In Figure S8 : Impact of the number of simulations on the standard error of annualized incidence for populations of 5250 MSM, comparing baseline testing frequency to testing every 90 days.
In each scenario, the minimum, maximum and interquartile range (IQR) vary little with increasing number of simulations, suggesting that by 20 simulations we have described most of the expected range in incidence for our model. The range of the IQR and extreme values for the scenario where men test every 90 days overlap those from the baseline scenario even after 100 simulations. Although the standard error of incidence per 100 person-years decreases slightly as the number of simulations increases, this value is driven more by the sample size of the population (set at 5250) and number of events (observed incidence), which are not affected by increasing the number of simulations. Even if simulations with a larger population (e.g. a simulation of the entire US population of MSM) or an extremely large number of simulations were to indicate that a difference in incidence could be considered 'significant' under traditional statistical inference , we only observed a 10% reduction in median incidence comparing baseline (near annual) testing with testing every 90 days, and the total volume and therefore cost of testing was so different for quarterly and annual testing that it is unlikely to be clinically meaningful or cost effective to decrease testing interval to less than annually, relative to interventions that increase the proportion of the infected population that achieves viral suppression.
